Upstream Bio, Inc.
UPB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $844,057 | $799,113 | $799,113 |
| - Cash | $325,892 | $25,833 | $17,051 |
| + Debt | $1,834 | $45 | $94 |
| Enterprise Value | $519,999 | $773,325 | $782,156 |
| Revenue | $2,370 | $2,380 | $1,212 |
| % Growth | -0.4% | 96.4% | – |
| Gross Profit | $2,370 | $2,380 | $1,212 |
| % Margin | 100% | 100% | 100% |
| EBITDA | -$77,675 | -$40,054 | -$23,902 |
| % Margin | -3,277.4% | -1,682.9% | -1,972.1% |
| Net Income | -$62,806 | -$20,537 | -$23,868 |
| % Margin | -2,650% | -862.9% | -1,969.3% |
| EPS Diluted | -1.49 | -1.05 | -0.66 |
| % Growth | -41.9% | -59.1% | – |
| Operating Cash Flow | -$59,172 | -$37,926 | -$19,021 |
| Capital Expenditures | -$511 | -$144 | -$82 |
| Free Cash Flow | -$59,683 | -$38,070 | -$19,103 |